These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 20651163)

  • 1. Rate of ESRD exceeds mortality among African Americans with hypertensive nephrosclerosis.
    Alves TP; Wang X; Wright JT; Appel LJ; Greene T; Norris K; Lewis J;
    J Am Soc Nephrol; 2010 Aug; 21(8):1361-9. PubMed ID: 20651163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The rationale and design of the AASK cohort study.
    Appel LJ; Middleton J; Miller ER; Lipkowitz M; Norris K; Agodoa LY; Bakris G; Douglas JG; Charleston J; Gassman J; Greene T; Jamerson K; Kusek JW; Lewis JA; Phillips RA; Rostand SG; Wright JT
    J Am Soc Nephrol; 2003 Jul; 14(7 Suppl 2):S166-72. PubMed ID: 12819323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of Cardiovascular Disease and Mortality in Young Adults With End-stage Renal Disease: An Analysis of the US Renal Data System.
    Modi ZJ; Lu Y; Ji N; Kapke A; Selewski DT; Dietrich X; Abbott K; Nallamothu BK; Schaubel DE; Saran R; Gipson DS
    JAMA Cardiol; 2019 Apr; 4(4):353-362. PubMed ID: 30892557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between body mass index and proteinuria in hypertensive nephrosclerosis: results from the African American Study of Kidney Disease and Hypertension (AASK) cohort.
    Toto RD; Greene T; Hebert LA; Hiremath L; Lea JP; Lewis JB; Pogue V; Sika M; Wang X;
    Am J Kidney Dis; 2010 Nov; 56(5):896-906. PubMed ID: 20801567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial.
    Norris K; Bourgoigne J; Gassman J; Hebert L; Middleton J; Phillips RA; Randall O; Rostand S; Sherer S; Toto RD; Wright JT; Wang X; Greene T; Appel LJ; Lewis J;
    Am J Kidney Dis; 2006 Nov; 48(5):739-51. PubMed ID: 17059993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteinuria and hypertensive nephrosclerosis in African Americans.
    Toto RD
    Kidney Int Suppl; 2004 Nov; (92):S102-4. PubMed ID: 15485398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report from the African American Study of Kidney Disease (AASK) Trial. AASK Pilot Study Investigators.
    Fogo A; Breyer JA; Smith MC; Cleveland WH; Agodoa L; Kirk KA; Glassock R
    Kidney Int; 1997 Jan; 51(1):244-52. PubMed ID: 8995739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of iothalamate-GFR and serum creatinine-based outcomes: acceleration in the rate of GFR decline in the African American Study of Kidney Disease and Hypertension.
    Lewis J; Greene T; Appel L; Contreras G; Douglas J; Lash J; Toto R; Van Lente F; Wang X; Wright JT;
    J Am Soc Nephrol; 2004 Dec; 15(12):3175-83. PubMed ID: 15579521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid progression to end-stage renal disease in young hypertensive African Americans with proteinuria.
    Obialo CI; Hewan-Lowe K
    J Natl Med Assoc; 1998 Nov; 90(11):649-55. PubMed ID: 9828579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating time to ESRD using kidney failure risk equations: results from the African American Study of Kidney Disease and Hypertension (AASK).
    Grams ME; Li L; Greene TH; Tin A; Sang Y; Kao WH; Lipkowitz MS; Wright JT; Chang AR; Astor BC; Appel LJ
    Am J Kidney Dis; 2015 Mar; 65(3):394-402. PubMed ID: 25441435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal prohormone brain natriuretic peptide as a predictor of cardiovascular disease and mortality in blacks with hypertensive kidney disease: the African American Study of Kidney Disease and Hypertension (AASK).
    Astor BC; Yi S; Hiremath L; Corbin T; Pogue V; Wilkening B; Peterson G; Lewis J; Lash JP; Van Lente F; Gassman J; Wang X; Bakris G; Appel LJ; Contreras G
    Circulation; 2008 Apr; 117(13):1685-92. PubMed ID: 18362234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylenetetrahydrofolate reductase (MTHFR) polymorphism A1298C (Glu429Ala) predicts decline in renal function over time in the African-American Study of Kidney Disease and Hypertension (AASK) Trial and Veterans Affairs Hypertension Cohort (VAHC).
    Fung MM; Salem RM; Lipkowitz MS; Bhatnagar V; Pandey B; Schork NJ; O'Connor DT;
    Nephrol Dial Transplant; 2012 Jan; 27(1):197-205. PubMed ID: 21613384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of high mortality in incident dialysis patients due to hypertensive nephrosclerosis: a multicenter prospective cohort study in Aichi, Japan.
    Inaguma D; Ito E; Takahashi K; Hayashi H; Koide S; Hasegawa M; Yuzawa Y;
    Clin Exp Nephrol; 2018 Dec; 22(6):1360-1370. PubMed ID: 29882111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.
    Agodoa LY; Appel L; Bakris GL; Beck G; Bourgoignie J; Briggs JP; Charleston J; Cheek D; Cleveland W; Douglas JG; Douglas M; Dowie D; Faulkner M; Gabriel A; Gassman J; Greene T; Hall Y; Hebert L; Hiremath L; Jamerson K; Johnson CJ; Kopple J; Kusek J; Lash J; Lea J; Lewis JB; Lipkowitz M; Massry S; Middleton J; Miller ER; Norris K; O'Connor D; Ojo A; Phillips RA; Pogue V; Rahman M; Randall OS; Rostand S; Schulman G; Smith W; Thornley-Brown D; Tisher CC; Toto RD; Wright JT; Xu S;
    JAMA; 2001 Jun; 285(21):2719-28. PubMed ID: 11386927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.
    Wright JT; Bakris G; Greene T; Agodoa LY; Appel LJ; Charleston J; Cheek D; Douglas-Baltimore JG; Gassman J; Glassock R; Hebert L; Jamerson K; Lewis J; Phillips RA; Toto RD; Middleton JP; Rostand SG;
    JAMA; 2002 Nov; 288(19):2421-31. PubMed ID: 12435255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risks of Adverse Events in Advanced CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
    Grams ME; Yang W; Rebholz CM; Wang X; Porter AC; Inker LA; Horwitz E; Sondheimer JH; Hamm LL; He J; Weir MR; Jaar BG; Shafi T; Appel LJ; Hsu CY;
    Am J Kidney Dis; 2017 Sep; 70(3):337-346. PubMed ID: 28366517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Clinical Trial and Cohort Study.
    Sika M; Lewis J; Douglas J; Erlinger T; Dowie D; Lipkowitz M; Lash J; Cornish-Zirker D; Peterson G; Toto R; Kusek J; Appel L; Kendrick C; Gassman J;
    Am J Kidney Dis; 2007 Jul; 50(1):78-89, 89.e1. PubMed ID: 17591527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD.
    Bhavsar NA; Appel LJ; Kusek JW; Contreras G; Bakris G; Coresh J; Astor BC;
    Am J Kidney Dis; 2011 Dec; 58(6):886-93. PubMed ID: 21944667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. African American Study of Kidney Disease and hypertension (AASK)--clinical trial update.
    Agodoa L
    Ethn Dis; 1998; 8(2):249-53. PubMed ID: 9681290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with biopsy-proven nephrosclerosis and moderately impaired renal function have a higher risk for cardiovascular disease: 15 years' experience in a single, kidney disease center.
    Suzuki H; Kobayashi K; Ishida Y; Kikuta T; Inoue T; Hamada U; Okada H
    Ther Adv Cardiovasc Dis; 2015 Jun; 9(3):77-86. PubMed ID: 25838316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.